GL1X · GenesisL1 explorer

MolNFT v1 · #149033 · protein

First domain of human bromodomain BRD4 in complex with inhibitor #17

6FO5: “First domain of human bromodomain BRD4 in complex with inhibitor #17”. X-ray diffraction, 1 ligand (DZH). MolNFT v1 #149033 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6FO5
Type
protein
Length
127 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
O60885
Ligands
DZH

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein127—O60885

Ligands and binding sites

  • DZH · ~{N}-[[4-[[7-ethyl-2,6-bis(oxidanylidene)purin-3-yl]methyl]phenyl]methyl]-2-oxidanylidene-1,3,4,5-tetrahydro-1-benzazepine-7-sulfonamide · ligand · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6FO5 · First domain of human bromodomain BRD4 in complex with inhibitor #17 · the same entry in another collection · chain A against A, TM-score 1.00
  • O60885 · AlphaFold monomer V2.0 prediction for bromodomain-containing protein 4 (O60885) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.